NCSM Q1 2026 Earnings Significant EPS Miss Despite Slight Stock Rise EXK Q1 2026 Earnings Strong Earnings Beat Propels Silver Producer Despite Tepid Market Reception SOS Q3 2018 Earnings Significant EPS Miss Amidst Operational Challenges SOBR Q3 2025 Earnings Net Loss of 144 per Share Amidst Operational Focus Vera Therapeutics Q1 2026 Earnings EPS Miss Highlights PreRevenue Stage Challenges Bolt Biotherapeutics Q1 2026 Earnings WiderThanExpected Loss Amid PreRevenue Stage